Date
01/20/2017
1600-2200 UTC
GoToMeeting Details
https://global.gotomeeting.com/join/374912925
Dial +1 (872) 240-3212
Access Code: 374-912-925
Audio PIN: Shown after joining the meeting
Meeting ID: 374-912-925
Observers:
Apologies
Meeting Files
Meeting minutes
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action |
---|---|---|---|---|
1 | Call to order and role call | JCA |
| |
2 | Conflicts of interest | JCA | ||
3 | Approval of minutes from Wellington | JCA |
| |
Use of Arabic or Roman numerals in FSNs Question from editors: "Anybody aware if there is guideline for using numbers vs. of Roman numerals? I can't find any related item in the current version of the ED guideline." A search of PubMed for "phase II antibodies" yielded numerous results related to Coxiella burnettii serology assays. A similar search for "Phase 2 antibodies" yielded no equivalent representations for other assays. Prior discussion related to Diabetes mellitus: Inconsistent use of Arabic/Roman numerals in Diabetes | ||||
Clinical genomics | IGR | The purpose of this discussion is to inform the EAG of the current status of clinical genomic projects within IHTSDO and to gain insight from the EAG as to priorities and potential resources for input to the overall IHTSDO genomics strategy, including scope, alignment with external standards, sources of truth, level of granularity, etc. |
| |
Drug Model update | TMO | Informational only: Update on current decisions from the Modeling project group (subgroup of EAG) | ||
6 | Extension of Cauastive agent to include Product | JCA/TMO | Update needed: There are specific use cases that more appropriately require the use of concepts from the Product hierarchy. The current approach has been to create matching Substances to allow for sufficient modeling, but in many cases this does not make sense and creates duplicate meanings. E.g. Adverse reaction to product; Allergy to food product, etc. |
|
8 | ECE Update | BGO | Update on ongoing issues with ECE
|
|
9 | Need to address semantics and placement of "Care plan for X" | JCA | Care plans Care plans - what are they ontologically? Initial discussion brief: https://jira.ihtsdotools.org/secure/attachment/18619/artf222780_Discussion_Plans.docx
|
|
Arteriography vs. Arteriogram | JCA | Current editorial guidance for "Arteriography of X" concepts recommends the addition of "Arteriogram of X". 7.8.4 Magnetic resonance imaging - "...It was agreed that the use of near synonyms is acceptable for these procedures (i.e. angiogram/arteriogram)." 7.8.8 Fluoroscopy imaging - Fluoroscopic arteriography An arteriogram is the output of the procedure and is more akin to a record artifact than a procedure. Question from the editorial team is whether this guidance is still acceptable due to a large number of requests in this area.?
|
| |
10 | Aligning SNOMED CT with clinical use cases | KCA/JCA | High level discussion on whether SNOMED CT is appropriately organized to support the highly variable granularity of content the are influenced by current EHR applications (i.e. single code recording of pre-coordinated content) and newer initiatives that are focused on capturing more structured data (e.g. CIMI, FHIR) | |
11 | Unilateral findings and procedures | JCA | Revisit of this issue following decision on laterality. From the discussion held in Uruguay:
In light of the approval of lateralized content into the International release, is there a compelling reason to keep these concepts (approx. 325). |
|
14 | Organizational groupers | JCA | The IHTSDO Editorial Panel would like guidance on the creation of a policy regarding the addition of fully defined "grouper" concepts that are not clinically useful, but are used primarily for navigation of the hierarchy. For example "Procedure on vena cava" without any specifics as to the nature of the procedure. | |
15 | Action item review | EAG | ||
16 | Meeting schedule 2017 | EAG |